Products for Research Use Only
RegisterLogin

Almorexant

CAT: 0804-HY-10805-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10805-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Almorexant (ACT 078573) is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively. Almorexant reversibly blocks signaling of orexin-A and orexin-B peptides. Almorexant totally blocked the intracellular Ca2+ signal pathway. Almorexant stimulates caspase-3 activity in AsPC-1 cells and induces apoptosis[1][2][3][4].
CAS Number
871224-64-5
Product Name Alternative
ACT 078573
UNSPSC
12352005
Target
Apoptosis; Calcium Channel; Caspase; Orexin Receptor (OX Receptor)
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Endocrinology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/almorexant.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CNC([C@@H](C1=CC=CC=C1)N2CCC3=CC(OC)=C(OC)C=C3[C@@H]2CCC4=CC=C(C(F)(F)F)C=C4)=O
Molecular Formula
C29H31F3N2O3
Molecular Weight
512.56
References & Citations
[1]Malherbe P, et al. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1) /orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists. Mol Pharmacol. 2009 Sep;76 (3) :618-31.|[2]Black SW, et al. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep. 2013 Mar 1;36 (3) :325-36.|[3]Dayot S, et al. In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma. Oncotarget. 2018 Jan 9;9 (6) :6952-6967.|[4]Dietrich H, et al. Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant. Psychopharmacology (Berl) . 2010 Oct;212 (2) :145-54.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
Calcium Channel; Caspase 3; OX1 Receptor; OX2 Receptor
Citation 01
Eur J Pharmacol. 2025 Jul 5:998:177498.|Oncotarget. 2018 Jan 9;9 (6) :6952-6967. |SSRN. 2025 Jun 18.|bioRxiv. 2023 Jul 19.|bioRxiv. 2025 February 25.|Cell Metab. 2018 Jul 3;28 (1) :118-129.e5.|Nat Neurosci. 2024 Sep;27 (9) :1774-1782.

Alternative Products

CatalogName
B3240-10Almorexant
B3241-10Almorexant hydrochloride
A12503-5Almorexant 5mg
AR-A05959-01Almorexant-d6
S2160-10mgAlmorexant HCl

Popular Products